IN2014MN01420A - - Google Patents
Info
- Publication number
- IN2014MN01420A IN2014MN01420A IN1420MUN2014A IN2014MN01420A IN 2014MN01420 A IN2014MN01420 A IN 2014MN01420A IN 1420MUN2014 A IN1420MUN2014 A IN 1420MUN2014A IN 2014MN01420 A IN2014MN01420 A IN 2014MN01420A
- Authority
- IN
- India
- Prior art keywords
- cells
- subpopulation
- pbmcs
- optionally
- treatment
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 abstract 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 abstract 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 abstract 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 abstract 1
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 abstract 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 abstract 1
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 abstract 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/414—Nervous system antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161570593P | 2011-12-14 | 2011-12-14 | |
| PCT/IL2012/050522 WO2013088441A1 (en) | 2011-12-14 | 2012-12-13 | Human monocyte sub-population for treatment of central nervous system injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01420A true IN2014MN01420A (pl) | 2015-04-03 |
Family
ID=48611950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1420MUN2014 IN2014MN01420A (pl) | 2011-12-14 | 2012-12-13 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9314483B2 (pl) |
| EP (1) | EP2790712B1 (pl) |
| JP (1) | JP6148679B2 (pl) |
| KR (1) | KR20140107439A (pl) |
| CN (1) | CN104159590A (pl) |
| AU (2) | AU2012354057B2 (pl) |
| BR (1) | BR112014014560A8 (pl) |
| DK (1) | DK2790712T3 (pl) |
| ES (1) | ES2604356T3 (pl) |
| HU (1) | HUE032096T2 (pl) |
| IN (1) | IN2014MN01420A (pl) |
| MX (1) | MX358589B (pl) |
| PL (1) | PL2790712T3 (pl) |
| PT (1) | PT2790712T (pl) |
| WO (1) | WO2013088441A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3226971B2 (ja) | 1992-08-04 | 2001-11-12 | 栗田工業株式会社 | イオン交換装置の採水−再生サイクル制御装置 |
| ES2786253T3 (es) | 2013-03-14 | 2020-10-09 | Immusoft Corp | Métodos para la diferenciación y transducción in vitro de células b de memoria con vectores virales pseudotipados vsv-g |
| BR112015029299A2 (pt) * | 2013-05-22 | 2017-07-25 | Yeda Res & Dev | subpopulação de monócitos humanos para tratamento de doenças e distúrbios oculares |
| EP4177336A1 (en) * | 2014-12-19 | 2023-05-10 | Immusoft Corporation | B cells for in vivo delivery of therapeutic agents |
| WO2017096246A1 (en) * | 2015-12-03 | 2017-06-08 | Temple University-Of The Commonwealth System Of Higher Education | Modulation of nad+ and nad+ metabolic pathways for treatment of disease |
| US20220146534A1 (en) * | 2019-01-16 | 2022-05-12 | Yeda Research And Development, Co., Ltd. | Biomarkers for CNS Disease Modification |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800812A (en) | 1995-09-15 | 1998-09-01 | Yeda Research And Development Co. Ltd. | Methods of use of mononuclear phagocytes to promote axonal regeneration |
| WO1998005795A1 (en) * | 1996-08-02 | 1998-02-12 | The Center For Blood Research, Inc. | Enrichment of dendritic cells from blood |
| US6267995B1 (en) | 1999-03-03 | 2001-07-31 | Pure World Botanicals, Inc. | Extract of Lepidium meyenii roots for pharmaceutical applications |
| AU2002353465B2 (en) | 2001-11-21 | 2008-10-16 | Yeda Research And Development Co. Ltd. | Process for the manufacture of human mononuclear phagocytic leukocytes |
| JP2011515470A (ja) * | 2008-03-28 | 2011-05-19 | ステムサイト インコーポレーテッド | 臍帯血細胞を用いた脳損傷の処置 |
| BR112015029299A2 (pt) * | 2013-05-22 | 2017-07-25 | Yeda Res & Dev | subpopulação de monócitos humanos para tratamento de doenças e distúrbios oculares |
-
2012
- 2012-12-13 WO PCT/IL2012/050522 patent/WO2013088441A1/en not_active Ceased
- 2012-12-13 HU HUE12858248A patent/HUE032096T2/en unknown
- 2012-12-13 KR KR1020147019424A patent/KR20140107439A/ko not_active Abandoned
- 2012-12-13 ES ES12858248.3T patent/ES2604356T3/es active Active
- 2012-12-13 BR BR112014014560A patent/BR112014014560A8/pt not_active IP Right Cessation
- 2012-12-13 MX MX2014007188A patent/MX358589B/es active IP Right Grant
- 2012-12-13 DK DK12858248.3T patent/DK2790712T3/en active
- 2012-12-13 PT PT128582483T patent/PT2790712T/pt unknown
- 2012-12-13 IN IN1420MUN2014 patent/IN2014MN01420A/en unknown
- 2012-12-13 PL PL12858248T patent/PL2790712T3/pl unknown
- 2012-12-13 AU AU2012354057A patent/AU2012354057B2/en not_active Ceased
- 2012-12-13 JP JP2014546730A patent/JP6148679B2/ja not_active Expired - Fee Related
- 2012-12-13 CN CN201280069645.XA patent/CN104159590A/zh active Pending
- 2012-12-13 EP EP12858248.3A patent/EP2790712B1/en not_active Not-in-force
-
2014
- 2014-06-12 US US14/303,212 patent/US9314483B2/en not_active Expired - Fee Related
-
2017
- 2017-10-31 AU AU2017254830A patent/AU2017254830A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUE032096T2 (en) | 2017-09-28 |
| MX2014007188A (es) | 2015-09-22 |
| JP2015501835A (ja) | 2015-01-19 |
| PT2790712T (pt) | 2016-12-02 |
| KR20140107439A (ko) | 2014-09-04 |
| ES2604356T3 (es) | 2017-03-06 |
| MX358589B (es) | 2018-08-27 |
| BR112014014560A8 (pt) | 2017-07-04 |
| WO2013088441A1 (en) | 2013-06-20 |
| EP2790712B1 (en) | 2016-08-31 |
| EP2790712A1 (en) | 2014-10-22 |
| DK2790712T3 (en) | 2016-12-19 |
| AU2012354057A1 (en) | 2014-07-31 |
| PL2790712T3 (pl) | 2017-04-28 |
| EP2790712A4 (en) | 2015-06-24 |
| US20140363411A1 (en) | 2014-12-11 |
| JP6148679B2 (ja) | 2017-06-14 |
| US9314483B2 (en) | 2016-04-19 |
| CN104159590A (zh) | 2014-11-19 |
| BR112014014560A2 (pt) | 2017-06-13 |
| AU2012354057B2 (en) | 2017-08-03 |
| AU2017254830A1 (en) | 2017-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282219B (en) | Humanized antibodies to pcsk9 for use in the treatment of certain groups of people | |
| EP2879710A4 (en) | Immunomodulatory modulating substances and methods of use therefor | |
| MX382102B (es) | Métodos mejorados para la elaboración de terapias celulares adoptivas. | |
| TN2013000468A1 (en) | Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms | |
| EP2736543A4 (en) | HEAT-RELATED METAL BASED COMPOSITIONS FOR WOUND HEALING MEDICAL AND USE PROCESSES | |
| MX2009009283A (es) | Anticuerpos anti-interleuquina -23r de ingenieria. | |
| MA34818B1 (fr) | Anticorps anti-pcsk9 et procédés d'utilisation | |
| EP2723851A4 (en) | SELF-RENEWING ENDODERMAL PRELIMINARY CELL LINES FROM HUMAN PLURIPOTENTIAL STEM CELLS AND METHOD OF USE THEREOF | |
| AU339269S (en) | Multimedia converter | |
| MY163057A (en) | Means and methods for trating dlblcl | |
| MX2014004696A (es) | Disposicion de articulos absorbentes desechables. | |
| MX353302B (es) | Tratamiento del dolor asociado con la dislocacion de endometrio basal. | |
| IL276077A (en) | The in vitro fertilization method with delayed embryo transfer and the use of mononuclear cells from peripheral blood | |
| GB201109238D0 (en) | Antibodies | |
| PL2736473T3 (pl) | Chłonny wyrób opasający, w którym pasek i chłonna wkładka mają określone kinetyczne współczynniki tarcia | |
| MX358589B (es) | Subpoblación de monocitos humanos para el tratamiento de daños al sistema nervioso central. | |
| AU342071S (en) | Large bowl | |
| GB2510524A (en) | Pulmonary hypertension | |
| IN2015DN00172A (pl) | ||
| MX2013012083A (es) | Biomarcadores para el tratamiento de mieloma multiple. | |
| GB2497255A (en) | Dice | |
| UA48629U (ru) | Способ обогащения магнетически очищенных cd34 позитивных стволовых гемопоэтических клеток | |
| UA70181U (ru) | Способ иммунологической оценки эффективности интерферонотерапии у больных с меланомой кожи | |
| GEU20131763Y (en) | Phototherapeutic device "aisi 2" | |
| CA143999S (en) | Diaper pail |